These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7586290)

  • 41. Simplified calculation of MRglc using PET.
    Phillips RL; London ED
    J Nucl Med; 1997 Aug; 38(8):1334. PubMed ID: 9255178
    [No Abstract]   [Full Text] [Related]  

  • 42. Identification of hibernating myocardium: a comparison between dobutamine echocardiography and study of perfusion and metabolism in patients with severe left ventricular dysfunction.
    Mariani MA; Palagi C; Donatelli F; Mengozzi G; Biadi O; Vanoli G; Landoni C; Paolini G; Lucignani G; Fazio F
    Am J Card Imaging; 1995 Jan; 9(1):1-8. PubMed ID: 7894227
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional brain imaging in 200 patients after whiplash injury.
    Otte A; Mueller-Brand J; Nitzsche EU; Wachter K; Ettlin TM
    J Nucl Med; 1997 Jun; 38(6):1002. PubMed ID: 9189162
    [No Abstract]   [Full Text] [Related]  

  • 44. Myocardial viability--what is the definition?
    Gropler RJ; Bergmann SR
    J Nucl Med; 1991 Jan; 32(1):10-2. PubMed ID: 1988611
    [No Abstract]   [Full Text] [Related]  

  • 45. Septal metabolic mismatch in LBBB.
    Burns RJ
    J Nucl Med; 1996 Nov; 37(11):1918-9. PubMed ID: 8917212
    [No Abstract]   [Full Text] [Related]  

  • 46. Fluorodeoxyglucose (FDG) and tumour metabolism.
    Van Wyngaarden KE; Pauwels EK
    Nucl Med Commun; 1995 Dec; 16(12):987-9. PubMed ID: 8719978
    [No Abstract]   [Full Text] [Related]  

  • 47. The value of quantitative analysis of glucose utilization in detection of myocardial viability by PET.
    Knuuti MJ; Nuutila P; Ruotsalainen U; Teräs M; Saraste M; Härkönen R; Ahonen A; Wegelius U; Haapanen A; Bergman J
    J Nucl Med; 1993 Dec; 34(12):2068-75. PubMed ID: 8254389
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Tomographic measurement of human cerebral glucose metabolism].
    Iwasaki Y; Konishi J; Makada Y; Yonekura Y
    Nihon Rinsho; 1991 Jul; 49(7):1528-31. PubMed ID: 1886247
    [No Abstract]   [Full Text] [Related]  

  • 49. Decreased uptake of iodinated branched fatty acid analog indicates metabolic alterations in ischemic myocardium.
    Tamaki N; Tadamura E; Kawamoto M; Magata Y; Yonekura Y; Fujibayashi Y; Nohara R; Sasayama S; Konishi J
    J Nucl Med; 1995 Nov; 36(11):1974-80. PubMed ID: 7472584
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of blood flow on the positron-emission tomographic determination of substrate transport rates.
    Holden JE
    Circulation; 1985 Nov; 72(5 Pt 2):IV72-6. PubMed ID: 3876895
    [No Abstract]   [Full Text] [Related]  

  • 51. FDG uptake within regionally stunned myocardium.
    McFalls EO; Ward H
    Am J Card Imaging; 1995 Oct; 9(4):269-74. PubMed ID: 8680144
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Positron emission tomography, bronchogenic carcinoma, and the adrenals.
    Lamki LM
    AJR Am J Roentgenol; 1997 May; 168(5):1361-2. PubMed ID: 9129445
    [No Abstract]   [Full Text] [Related]  

  • 53. Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans.
    Gropler RJ; Siegel BA; Lee KJ; Moerlein SM; Perry DJ; Bergmann SR; Geltman EM
    J Nucl Med; 1990 Nov; 31(11):1749-56. PubMed ID: 2230987
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prediction of reversibility of wall motion abnormalities after revascularization using F18-fluorodeoxyglucose single photon emission computed tomography.
    Bax JJ; Cornel JH; Visser FC; Huybregts MA; Van Lingen A
    Eur Heart J; 1996 Mar; 17(3):480-1. PubMed ID: 8737225
    [No Abstract]   [Full Text] [Related]  

  • 55. [Myocardial blood flow and glucose metabolism in patients with myocardial infarction evaluated by positron emission tomography: comparison with left ventriculography].
    Fudo T; Kambara H; Hashimoto T; Hayashi M; Kawai C; Senda M; Tamaki N; Yonekura Y
    J Cardiol; 1988 Mar; 18(1):13-20. PubMed ID: 3265437
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessment of myocardial viability in chronic left ventricular dysfunction.
    Ling LH; Tei C; Pellikka PA
    J Cardiol; 1995 Apr; 25(4):199-211. PubMed ID: 7752054
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of the duration of fasting on myocardial fluorine-18-fluorodeoxyglucose positron emission tomography images in normal males.
    Yamanouchi M; Yoshida K; Niwayama H; Nakagawa K; Aioi S; Shikama N; Himi T; Imazeki K; Itoh Y; Masuda Y
    Jpn Circ J; 1996 Jun; 60(6):319-27. PubMed ID: 8844297
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical significance of nuclear medicine in the presurgical diagnosis of epilepsy].
    Grünwald F; Menzel C; Elger CE; Biersack HJ
    Nuklearmedizin; 1997 Mar; 36(2):3-5. PubMed ID: 9148270
    [No Abstract]   [Full Text] [Related]  

  • 59. Highlights of the annual meeting of the European Association of Nuclear Medicine, Düsseldorf 1994.
    Knapp WH
    Eur J Nucl Med; 1995 Jan; 22(1):69-80. PubMed ID: 7698158
    [No Abstract]   [Full Text] [Related]  

  • 60. Positron emission tomography in the clinical evaluation of metastatic cancer.
    Fischman AJ
    J Clin Oncol; 1996 Mar; 14(3):691-6. PubMed ID: 8622012
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.